Recent Updates
Recently added Catalysts
VIR Positive Sentiment Score: 70/100

Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference

Tuesday, February 28, 2023 1 min read
Key Takeaway: Vir Biotechnology, Inc. has announced its participation in the Cowen 43rd Annual Health Care Conference. Executive Vice President Bolyn Hubby will join a panel discussion on infectious diseases set for March 7. The event reflects the company's commitment to address critical health issues and engage with industry counterparts. A live webcast of the session will be available for stakeholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent industry conference showcases Vir's engagement.
  • The panel focuses on infectious diseases, aligning with Vir's mission.
  • Live webcast increases accessibility for stakeholders and investors.

Full Press Release Details

SAN FRANCISCO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Bolyn Hubby, Ph.D., Executive Vice President and Chief Corporate Affairs Officer, will participate in a panel focused on infectious diseases at the Cowen 43rd Annual Health Care Conference on Tuesday, March 7, at 6:10 a.m. PT / 9:10 a.m. ET.
A live webcast of the panel can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.
About Vir Biotechnology
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B and D viruses, influenza A and human immunodeficiency virus. Vir routinely posts information that may be important to investors on its website.

Tags

Cowen Healthcare Conference

Frequently Asked Questions

When is the Cowen 43rd Annual Health Care Conference?

The conference is on March 7, 2023, at 6:10 a.m. PT / 9:10 a.m. ET.

Who will represent Vir Biotechnology at the conference?

Bolyn Hubby, Ph.D., Executive Vice President, will participate in the panel.

How can I access the panel webcast?

The webcast will be available in the Investors section on Vir's website.

What diseases does Vir Biotechnology focus on?

Vir focuses on COVID-19, hepatitis B and D, influenza A, and HIV.

Where can I find investor information about Vir?

Important investor information is routinely posted on Vir Biotechnology's website.

Tags: VIR Viatris Investor Conferences Healthcare Vir Biotechnology infectious diseases Cowen Conference healthcare industry
Last updated: Feb 28, 2023